• Products
  • Community
  • Markets
  • Brokers
  • More
Get started
  • Markets
  • /USA
  • /Stocks
  • /Ideas
LULU eyes on $243-248: Decent Support to buy after Earnings DumpLULU earnings report caused a severe dip in price. It is now testing a serious support at $243.81-248.17 Look to hold, or stab below and come back above. . Last Plot that gave PERFECT entry and exit: .
NASDAQ:LULU
by EuroMotif
33
Newmont showing an extremely positive outlookSome notes which can be used as arguments to the bullish outlook: The stock is above the 200D and even the 200W EMA. Large inverted head and shoulders structure which presents an opportunity leading up to 80$ which also turns out to be the resistance level tested in 1987 and 2022. Locally looks like someone has been accumulating. Gold's bullish price into price discovery, geo-political uncertainty only re-affirms the thesis. My expectation are that by the end of this year if not by middle of next year that the 80$ price target will be reached. There is a small stop at 65$ but I am highly doubtful we will stay a lot of time there.
NYSE:NEMLong
by idtasov
11
AMSC eyes on $29.20/40: Key Resistance holding BreakOut to $35AMSC has been grinding upwards in a nice uptrend. Currently testing a serious resistance $29.20-20.40 Break should continue grind to next res around $35
NASDAQ:AMSC
by EuroMotif
Updated
Understanding Time-Based vs. Volume-Based Stock Price Levels. P1Understanding Time-Based vs. Volume-Based Stock Price Levels Key Concepts: Time-Based Price Level Definition: The duration a stock spends at a specific price. Example: A stock trades at $50 for 2 hours but with only 100 volume . Significance: The market accepts $50 as fair value because it spends more time there. Moves away are slower. Volume-Based Price Level Definition: The amount of shares traded at a specific price. Example: A stock trades at $40 for 5 minutes but with 200 volume . Significance: $40 may be a discounted price or manipulation , depending on history. Interpreting the Levels: 1. Fair Value (Time-Based) Prolonged time at a price (e.g., $50) = Market consensus on fair value. Low volume + high time = Stability; reversals are gradual. 2. Discounted Price (Volume-Based) High volume + short time = Potential discount if the price was a previous fair value . ✅ Confirmed Discount: Example: Milk historically fair at $1 → Drops to $1 (high volume) → Rebounds to $2. Traders recognize the discount, leading to rapid buying. ❌ Manipulation/Fakeout: Example: Price drops to $0.15 (no history) → High volume but weak rebound. 3. Manipulation/Fake-Out High volume at new/unfamiliar levels (e.g., $0.15) lacks conviction. Practical Takeaways: Prioritize Historical Context: High volume + past fair value = Strong signal (e.g., $1 → $2). Speed of Moves: Discounted prices ($1) → Fast, high-volume rallies. Combine Time & Volume: Fair value = Time > Volume. Discounts = Volume > Time.
NASDAQ:MSFT
by emad_arshad_alam
Virgin Galactic to MarsMy predictions are often times too far out for most people to see and 9 times out of 10 I give a minimum prediction. Well, this time my prediction will go a bit further. I predict Virgin Galactic to $4000. Stay tuned!
NYSE:SPCELong
by illagodzilla
NBIS - bullish cross on 50 and 200MAThe golden cross hasn't happened yet but is about to happen. Keep this in your radar.
NASDAQ:NBISLong
by ramaraju_ca
CRWD watch $450 then 437: Supports to buy after Earnings dumpCRWD ran up into the earnings report then sold the news. Initial drop hit a minor support zone $449.08-451.81 May well drop to semi-major support $436.67-437.51
NASDAQ:CRWD
by EuroMotif
Updated
Intercorp Financial (IFS) Gains in Peru’s EconomyIntercorp Financial Services Inc. (IFS) is a leading financial holding company in Peru, offering banking, insurance, and wealth management services through its subsidiaries Interbank, Interseguro, and Inteligo. Known for its wide range of products, IFS supports customer needs with personal loans, mortgages, life insurance, and investment solutions. The company’s growth is driven by Peru’s expanding middle class, rising consumer credit demand, and increasing financial inclusion across the country. On the chart, we see a confirmation bar with rising volume, signaling strong buying interest. The price has moved into the momentum zone, breaking above the .236 Fibonacci level. Traders can use the Fibonacci snap tool to set a trailing stop just below the .236 level, allowing the position to stay protected while capturing further upside.
NYSE:IFSLong
by traderspro_charts
MercadoLibre Pulls BackMercadoLibre rallied to new highs last month, and some traders may see an opportunity in its latest pullback. The first pattern on today’s chart is the $2,374.54 level. MELI first touched that price on February 21 after reporting strong earnings. The stock gapped above the level in May on another strong quarterly report and has now retested it. Will the old resistance emerge as new support? Second, price gains after the last two quarterly reports may reflect positive fundamental sentiment in the Latin American e-commerce company. Third, stochastics have dipped to an oversold condition. Check out TradingView's The Leap competition sponsored by TradeStation. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. If you're born to trade, we could be for you. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
NASDAQ:MELI
by TradeStation
AFRM eyes on $50.66: Semi-Major Genesis fib for High Support AFRM has been showing considerable strength. Hit a Geneiss fib above and fell back to sister fib. Strong Bull trend would hold this fib into new highs. $50.66 is the immediate floor to hold $49.17 is a minor fib for a speed brake. $47.60 is Bulls' Last Stand to hold uptrend. ============================================= .
NASDAQ:AFRM
by EuroMotif
Updated
22
WALMART testing its 1D MA50! Will it bounce?Walmart (WMT) hit yesterday its 1D MA50 (blue trend-line) for the first time since April 21. It appears that the rebound from the Trade War Low has turned sideways on a Double Top formation and the 1D MA50 is the first Support to be tested, with the 1D MA200 (orange trend-line) following. This pattern resembles the August - September 2022 Bull Flag, which despite breaking below its 1D MA50, it resumed the uptrend shortly after and hit the 1.382 Fibonacci extension before the next 1D MA50 pull-back. As a result, we expect the stock to reach $110.00 (Fib 1.382) by the end of the Summer. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:WMT
by TradingShot
Where is $CRWV headed to?CoreWeave (NASDAQ: CRWV): Pros Explosive revenue growth -Q1 2025 revenue surged 420% year-over-year to $981.6 million, up from $188.7 million. -Consensus expects revenue could double in 2025 and reach $16 billion by 2027. High adjusted EBITDA margins -Adjusted EBITDA margin around 62% in Q1 and ~64% for 2024. Strategic customer contracts -$11.9 b OpenAI deal and partnership with Google Cloud to support OpenAI workloads. -$7 b lease agreement with Applied Digital over 15 years. Backed by top-tier capital providers -Investors include Nvidia, Microsoft, Blackstone, Magnetar, Fidelity. -IPO raised $1.5 b even after scaling down, plus interest in refinancing $1.5 b debt. Market leadership in GPU cloud -Positioned as a “neocloud” AI infrastructure powerhouse, offering specialized high-performance GPU services to hyperscalers. Cons -Massive capital intensity & debt -Carried ~$8 b in debt as of end-2024; raising more to refinance high-yield credit. -Depreciation and interest charges weigh on GAAP profits GAAP losses remain significant -Q1 net loss of $314 million due to high depreciation/interest; GAAP net loss margin ~32%. -Non-cash adjusted figures hide underlying capital burn. Customer concentration risk -Microsoft accounted for ~62% of 2024 revenue; OpenAI and Google help diversify, but client dependency remains. IPO headwinds & pricing struggles -IPO priced at\$40 (reduced from $47–55). -Seen as largest tech IPO since 2021, but faced investor concerns over sustainability. Valuation and competition concerns -Stock is up ~250–300% since IPO—possible bubble risk. -Faces competition from Big Tech hyperscalers and other AI compute providers -Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy or sell any securities. Stock prices, valuations, and performance metrics are subject to change and may be outdated. Always conduct your own due diligence and consult with a licensed financial advisor before making investment decisions. The information presented may contain inaccuracies and should not be solely relied upon for financial decisions. I am not personally liable for your own losses, this is not financial advise.
NASDAQ:CRWV
by bossout10
33
"Still Holding IONQ — $43.35 Is the Real Breakout""IONQ Hit My Target Twice — Now I’m Waiting for a $43.35 Breakout" @Gerrie77
NYSE:IONQLong
by ProfittoPath
22
Where is HIMS set to go next?Overview of Hims & Hers Health (NYSE: HIMS): Pros Expanding into weight-loss treatments -Hims successfully entered the high-demand GLP‑1 weight-loss space by selling compounded semaglutide during shortages. With branded Wegovy now available on their platform in partnership with Novo Nordisk, they’ve broadened their offering. Solid growth & rising profitability -Revenue surged ~18% in 2024 to $1.78 b ttm, with annual net income of $164 m. -Q1 2025 reported >100% YoY revenue growth ($586 m) with expected profit of 20¢/share. Strong gross margins -At around 80–88%, comparable to peer telehealth platforms. Diverse healthcare offerings -Beyond weight loss: sexual health, skincare, hair loss, mental health via DTC model. Expanded further via European acquisition of ZAVA (~1.3 m subscribers). Undervalued relative to future earnings -Analysts project 2030 revenues of $6.5 b—implying mid‑20s% CAGR. With projected EPS ~$1.5 b, current multiples (P/E ~40x) might look reasonable long term. Cons GLP‑1 strategy under pressure -The end of compounding allowances by FDA reduced their low-cost advantage. -Dependence on cash-pay vs. insurer coverage may limit growth if insurers cap co-pays. High valuation with risk -Trading at ~84x trailing EPS and ~70x forward EPS—wide margin for missteps. -Analysts average target at $38 (≈ 33% downside), 12 rate it a 'Hold'. Competitive & regulatory headwinds -Market crowded with telehealth players like Ro, Noom, CVS, and insurers which may undercut cash-pay model. -Legal scrutiny over “personalized” compounded products persists; Novo lawsuits underway. Reputation & controversy -CEO’s political donation stirred backlash; regulatory scrutiny around ads and compounding practices. -Platform has faced occasional service and customer trust issues. -Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy or sell any securities. Stock prices, valuations, and performance metrics are subject to change and may be outdated. Always conduct your own due diligence and consult with a licensed financial advisor before making investment decisions. The information presented may contain inaccuracies and should not be solely relied upon for financial decisions. I am not personally liable for your own losses, this is not financial advise.
NYSE:HIMS
by bossout10
11
NVDA Daily 12th JuneI draw Fibonacci retracement and specified Fib Golden Zone. I believe that the price may drop to 38% Fib level, after which it will be ready to move towards the TPs.
NASDAQ:NVDALong
by IIAF
MARA - Elliott Wave CountThis is my personal MARA EW count, on the monthly timeframe. Looks bullish and promising, we'll see...
NASDAQ:MARALong
by FrancescoPavan92
WARBY PARKER to continue its recovery to $34 and beyond#inverseheadandshoulders They want to have 900 retail locations currently operating 271 in the US and 5 in Canada.
NYSE:WRBYLong
by BallaJi
APPLE Long 200 is very strong resistance. US-China deal will have a short term positive impact on APPL.
NASDAQ:AAPLLong
by BatuMeftun
Intel (INTC) Shares Drop Over 6% in a DayIntel (INTC) Shares Drop Over 6% in a Day As shown on the Intel (INTC) chart, after Tuesday’s candle closed above $21, the price dropped sharply on Wednesday. INTC was the worst-performing stock of the day among the components of the S&P 500 index (US SPX 500 mini on FXOpen). Why Did INTC Shares Fall? The decline is linked to growing competitive pressure. According to media reports: → On one hand, AMD continues to rapidly expand its share of the server CPU market. A report by Mercury shows that the company already controls 40% of the segment and could match Intel as early as next year. → On the other hand, Nvidia is preparing to launch two accelerated processing units (APUs) for the consumer market, which will combine CPU and GPU capabilities in a single product. Technical Analysis of the INTC Chart In 2025, the price remains: → within a broad downward trend (marked in red); → supported by the $18.50–$20 zone. Meanwhile, price fluctuations in May and June are forming a narrowing triangle (marked in black). Following the recent negative news, it is possible that INTC shares could fall towards the lower boundary of the triangle — or even retest the psychologically important $20 level. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NASDAQ:INTC
by FXOpen
11
OSUR - Bull SSS Flag - Long setupOSUR - Long setup. Here we have another Bull SSS Flag. Money flow is positive. The President & CEO bought some shares in February.
NASDAQ:OSURLong
by AcornWealthCorp
FSLR (First Solar Inc.) | High-Conviction Recovery PlayPublished by WaverVanir International LLC | 06/12/2025 FSLR has reclaimed key structure after sweeping a weak low and entering a high-volume discount zone (~$120–135). Price has aggressively surged, forming internal BOS and CHoCH patterns—confirming a liquidity reversal and positioning for a move toward premium supply levels. 🔍 Technical Framework: ✅ Smart Money CHoCH → BOS confirms directional shift 🔵 0.618–0.786 retracement from recent impulse has been respected 🟣 Short-term equilibrium sits around $198.87 — first major resistance 🎯 Long-term target: $261.45 (aligned with strong high & 1.786 Fib extension) 📉 Risk Management & Trade Idea: Ideal entry zone: $162–$170 Stop-loss idea: Below $148 to protect structure TP1: $198 TP2 (stretch): $261.45 📈 Macro Catalyst Watch: U.S. solar investment incentives (IRA policy continuation) ☀️ Semiconductor demand for solar manufacturing tech 🧠⚡ International solar adoption across EM markets 📊 Probability Outlook: Bullish continuation to $198+: 70% Push toward $261 zone by Q4 2025: 45% Rejection back into $145–150: 15% Volume confirms smart money intent. Pullbacks offer asymmetric entries if structure holds. #FSLR NASDAQ:FSLR #SolarEnergy #SmartMoneyConcepts #WaverVanir #CleanEnergyStocks #SwingTrading #FibAnalysis #InstitutionalFlow
NASDAQ:FSLRLong
by Wavervanir_International_LLC
REGN | Regeneron Pharmaceuticals – Macro Reaccumulation SetupPublished by WaverVanir International LLC | 06/12/2025 Regeneron has completed a deep retracement, touching the 0.886 Fibonacci level (~$567) and entering a strong discount zone, coinciding with a weak low sweep and increasing volume — suggesting potential accumulation by institutions. 🔍 Key Confluences: 🔄 Internal CHoCH and BOS structure shift indicates short-term reversal 🔵 Entered macro discount territory with a clean sweep of liquidity below $485 🟡 Targeting major inefficiency and liquidity void around $766.75, aligning with 0.5 retracement and prior equilibrium 🟥 Supply zones between $640–$720 may offer resistance/partial profit-taking zones 📉 Risk Framework: Entry consideration: $500–$520 Stop loss idea: Below $475 (invalidate weak low sweep) Primary Target: $766.75 Secondary Target (Extended): $818–$852 🧠 Fundamental & Macro Watch: Upcoming trial results or FDA action could act as a key catalyst Biotech sector sentiment tied to macro healthcare policy and AI-integration for drug discovery Recent earnings showed strong forward guidance – potential re-rating ahead 📈 Probabilistic Outlook: Bullish retracement toward $766.75: 70% Extended bearish continuation (below $485): 15% Sideways chop: 15% 🧭 Smart money often reacts to extreme fear – REGN may be entering a mark-up phase if confirmed with institutional follow-through. #REGN NASDAQ:REGN #SmartMoneyConcepts #FibConfluence #WaverVanir #BiotechStocks #SwingTrading #TechnicalAnalysis #InstitutionalOrderFlow
NASDAQ:REGNLong
by Wavervanir_International_LLC
BABA (Alibaba Group Holdings) | 1D Chart OutlookPublished by WaverVanir International LLC | 06/11/2025 BABA has broken out of its multi-year base and is now in a potential macro reversal structure. The current retracement near $120 could act as a higher low before a continuation toward the unfilled liquidity zone around $183.13, a major inefficiency level from late 2021. 🔍 Key Technicals: ✅ Long accumulation between 2022–2024 🚀 Breakout above $100 confirmed by strong volume 🔁 Pullback into prior breakout zone (~$115–$120) could offer optimal re-entry 📈 Target: $183.13 (Gap-fill + structural resistance) 📉 Risk Management: 🛑 Invalid below $105 (structure break) 🎯 Risk/Reward favorable if entries are scaled in sub-$125 📊 Probability Weighted Bias: Bullish Continuation: 65% Consolidation: 25% Breakdown/Invalidation: 10% 🧠 Macro Catalyst Watch: China stimulus or regulatory easing 📉🪙 Fed rate pivot & USD weakness 💵🕊️ Earnings growth rebound in Alibaba’s cloud segment 🌐📊 This setup reflects asymmetric potential as tech re-rates globally. Risk-defined, sentiment-watching, and catalyst-aware traders may consider positioning for a medium-term swing. #Alibaba NYSE:BABA #SMC #GapFill #TradingStrategy #WaverVanir #TechStocks #ChinaEquities #SwingTrading
NYSE:BABALong
by Wavervanir_International_LLC
112233445566778899101011111212131314141515161617171818191920202121222223232424252526262727282829293030313132323333343435353636373738383939404041414242
…999999

Select market data provided by ICE Data services. Select reference data provided by FactSet. Copyright © 2025 FactSet Research Systems Inc.© 2025 TradingView, Inc.

More than a product
  • Supercharts
Screeners
  • Stocks
  • ETFs
  • Bonds
  • Crypto coins
  • CEX pairs
  • DEX pairs
  • Pine
Heatmaps
  • Stocks
  • ETFs
  • Crypto
Calendars
  • Economic
  • Earnings
  • Dividends
More products
  • Yield curves
  • Options
  • News Flow
  • Pine Script®
Apps
  • Mobile
  • Desktop
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
Tools & subscriptions
  • Features
  • Pricing
  • Market data
Trading
  • Overview
  • Brokers
Special offers
  • CME Group futures
  • Eurex futures
  • US stocks bundle
About company
  • Who we are
  • Manifesto
  • Athletes
  • Blog
  • Careers
  • Media kit
Merch
  • TradingView store
  • Tarot cards for traders
  • The C63 TradeTime
Policies & security
  • Terms of Use
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Accessibility Statement
  • Security vulnerability
  • Status page
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Look FirstLook First